MA43962A - Animaux non humains possédant un gène angptl8 modifié - Google Patents
Animaux non humains possédant un gène angptl8 modifiéInfo
- Publication number
- MA43962A MA43962A MA043962A MA43962A MA43962A MA 43962 A MA43962 A MA 43962A MA 043962 A MA043962 A MA 043962A MA 43962 A MA43962 A MA 43962A MA 43962 A MA43962 A MA 43962A
- Authority
- MA
- Morocco
- Prior art keywords
- human animals
- angptl8 gene
- modified
- modified angptl8
- gene
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/515—Angiogenesic factors; Angiogenin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/20—Animal model comprising regulated expression system
- A01K2217/206—Animal model comprising tissue-specific expression system, e.g. tissue specific expression of transgene, of Cre recombinase
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0306—Animal model for genetic diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/035—Animal model for multifactorial diseases
- A01K2267/0375—Animal model for cardiovascular diseases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pathology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662291446P | 2016-02-04 | 2016-02-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA43962A true MA43962A (fr) | 2018-12-12 |
Family
ID=58044217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA043962A MA43962A (fr) | 2016-02-04 | 2017-02-03 | Animaux non humains possédant un gène angptl8 modifié |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10582702B2 (fr) |
| EP (1) | EP3411392B1 (fr) |
| JP (1) | JP6843872B2 (fr) |
| KR (1) | KR102487839B1 (fr) |
| CN (1) | CN108779159B (fr) |
| AU (1) | AU2017213627B2 (fr) |
| CA (1) | CA3012693C (fr) |
| ES (1) | ES2908669T3 (fr) |
| IL (1) | IL260620B (fr) |
| MA (1) | MA43962A (fr) |
| MX (1) | MX2018009513A (fr) |
| RU (1) | RU2742354C2 (fr) |
| SG (1) | SG11201806176PA (fr) |
| WO (1) | WO2017136712A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2962277T3 (es) | 2017-09-29 | 2024-03-18 | Regeneron Pharma | Roedores que comprenden un locus Ttr humanizado y métodos de uso |
| HRP20240999T1 (hr) | 2018-07-16 | 2024-10-25 | Regeneron Pharmaceuticals, Inc. | Glodavački modeli bolesti ditra i njihova upotreba |
| WO2020206139A1 (fr) | 2019-04-04 | 2020-10-08 | Regeneron Pharmaceuticals, Inc. | Animaux non humains comprenant un locus facteur 12 de coagulation humanisé |
| EP3801011A1 (fr) | 2019-06-04 | 2021-04-14 | Regeneron Pharmaceuticals, Inc. | Animaux non humains comprenant un locus ttr humanisé ayant une mutation bêta-slip et procédés d'utilisation |
| AU2020289581B2 (en) | 2019-06-07 | 2024-11-21 | Regeneron Pharmaceuticals, Inc. | Non-human animals comprising a humanized albumin locus |
| CN114671943B (zh) * | 2022-04-29 | 2023-05-05 | 四川大学 | 一种鱼类摄食调控蛋白的制备和应用 |
| CN119367545B (zh) * | 2025-01-02 | 2025-04-08 | 山东第一医科大学(山东省医学科学院) | 靶向干预ANGPTL8 mRNA在制备治疗高同型半胱氨酸血症药物中的应用 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5670356A (en) | 1994-12-12 | 1997-09-23 | Promega Corporation | Modified luciferase |
| US5874304A (en) | 1996-01-18 | 1999-02-23 | University Of Florida Research Foundation, Inc. | Humanized green fluorescent protein genes and methods |
| US6586251B2 (en) | 2000-10-31 | 2003-07-01 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| EP1451578B1 (fr) * | 2001-11-16 | 2013-08-21 | Genentech, Inc. | Utilisation d' antagonistes de angptl3 pour le traitement des maladies inflammatoires du foie |
| US20050283054A1 (en) | 2004-06-18 | 2005-12-22 | Banner Health | Evaluation of a treatment to decrease the risk of a progressive brain disorder or to slow brain aging |
| AU2005295269B2 (en) | 2004-10-19 | 2010-05-13 | Regeneron Pharmaceuticals, Inc. | Method for generating an animal homozygous for a genetic modification |
| JP2008532516A (ja) * | 2005-03-11 | 2008-08-21 | ジェネンテック・インコーポレーテッド | 遺伝子破壊、組成物、およびそれに関連する方法 |
| RU2425880C2 (ru) * | 2009-07-30 | 2011-08-10 | Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН | Способ получения трансгенных мышей |
| WO2011020014A1 (fr) | 2009-08-14 | 2011-02-17 | Regeneron Pharmaceuticals, Inc. | Cassette à auto-suppression dépendant de la différenciation régulée par un promoteur |
| CA3040377C (fr) | 2009-10-06 | 2025-12-30 | Yale University | Souris genetiquement modifiees et prise de greffe qui compose la coupe d'un gene humain thrombopoietique (tpo) |
| ES3040596T3 (en) | 2011-02-15 | 2025-11-03 | Regeneron Pharma | Humanized m-csf mice and uses thereof |
| RS56330B1 (sr) * | 2011-10-28 | 2017-12-29 | Regeneron Pharma | Genetski modifikovani miševi sa ekspresijom himernih molekula klase ii glavnog kompleksa histokompatibilnosti (mhc) |
| MY186903A (en) | 2011-10-28 | 2021-08-26 | Regeneron Pharma | Humanized il-6 and il-6 receptor |
| US8962913B2 (en) | 2012-06-18 | 2015-02-24 | Regeneron Pharmaceuticals, Inc. | Humanized IL-7 rodents |
| KR102287541B1 (ko) | 2012-09-07 | 2021-08-10 | 예일 유니버시티 | 유전적으로 변형된 비-인간 동물 및 이것들의 사용 방법 |
| AU2014218931C1 (en) | 2013-02-20 | 2020-05-14 | Regeneron Pharmaceuticals, Inc. | Genetic modification of rats |
| DK3175706T3 (en) | 2013-09-23 | 2019-03-04 | Regeneron Pharma | Non-human animals with a humanized signal regulatory protein gene |
| SMT201900177T1 (it) | 2013-10-15 | 2019-05-10 | Regeneron Pharma | Animali con il-15 umanizzata |
| CN105792646B (zh) | 2013-11-19 | 2018-03-02 | 瑞泽恩制药公司 | 具有人源化的b细胞活化因子基因的非人动物 |
| SG10201811701YA (en) | 2013-11-19 | 2019-01-30 | Regeneron Pharma | Non-human animals having a humanized a proliferation-inducing ligand gene |
| NO2785538T3 (fr) | 2014-05-07 | 2018-08-04 | ||
| KR20250096864A (ko) | 2014-05-19 | 2025-06-27 | 리제너론 파마슈티칼스 인코포레이티드 | 인간 epo를 발현하는 유전자 변형된 비-인간 동물 |
| HUE048677T2 (hu) * | 2014-06-19 | 2020-07-28 | Regeneron Pharma | Humanizált programozott sejthalál 1 génnel rendelkezõ nem-humán állatok |
| US10071139B2 (en) * | 2014-10-03 | 2018-09-11 | Ngm Biopharmaceuticals, Inc. | Methods for treatment of conditions associated with elevated triglycerides with an ANGPTL8 polypeptide fragment |
| KR102617691B1 (ko) | 2014-12-05 | 2023-12-27 | 리제너론 파마슈티칼스 인코포레이티드 | 인간화 분화 클러스터 47 유전자를 가진 비인간 동물 |
| NZ731954A (en) | 2014-12-09 | 2024-11-29 | Regeneron Pharma | Non-human animals having a humanized cluster of differentiation 274 gene |
| CN105671189A (zh) * | 2016-04-03 | 2016-06-15 | 信阳师范学院 | 一种基于黄牛Angptl8基因单核苷酸多态性的分子育种方法 |
-
2017
- 2017-02-03 CN CN201780015045.8A patent/CN108779159B/zh not_active Expired - Fee Related
- 2017-02-03 SG SG11201806176PA patent/SG11201806176PA/en unknown
- 2017-02-03 KR KR1020187023863A patent/KR102487839B1/ko active Active
- 2017-02-03 MX MX2018009513A patent/MX2018009513A/es unknown
- 2017-02-03 JP JP2018540723A patent/JP6843872B2/ja not_active Expired - Fee Related
- 2017-02-03 US US15/424,322 patent/US10582702B2/en active Active
- 2017-02-03 EP EP17705276.8A patent/EP3411392B1/fr active Active
- 2017-02-03 AU AU2017213627A patent/AU2017213627B2/en not_active Ceased
- 2017-02-03 WO PCT/US2017/016487 patent/WO2017136712A1/fr not_active Ceased
- 2017-02-03 RU RU2018130003A patent/RU2742354C2/ru active
- 2017-02-03 ES ES17705276T patent/ES2908669T3/es active Active
- 2017-02-03 CA CA3012693A patent/CA3012693C/fr active Active
- 2017-02-03 MA MA043962A patent/MA43962A/fr unknown
-
2018
- 2018-07-16 IL IL260620A patent/IL260620B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201806176PA (en) | 2018-08-30 |
| ES2908669T3 (es) | 2022-05-03 |
| IL260620B (en) | 2021-02-28 |
| MX2018009513A (es) | 2019-01-31 |
| US10582702B2 (en) | 2020-03-10 |
| RU2018130003A (ru) | 2020-03-04 |
| US20170245481A1 (en) | 2017-08-31 |
| CA3012693A1 (fr) | 2017-08-10 |
| CN108779159B (zh) | 2022-12-30 |
| JP2019505216A (ja) | 2019-02-28 |
| RU2742354C2 (ru) | 2021-02-05 |
| HK1258506A1 (en) | 2019-11-15 |
| CN108779159A (zh) | 2018-11-09 |
| KR20180104052A (ko) | 2018-09-19 |
| WO2017136712A1 (fr) | 2017-08-10 |
| JP6843872B2 (ja) | 2021-03-17 |
| AU2017213627B2 (en) | 2022-05-19 |
| EP3411392B1 (fr) | 2021-12-29 |
| EP3411392A1 (fr) | 2018-12-12 |
| AU2017213627A1 (en) | 2018-08-09 |
| RU2018130003A3 (fr) | 2020-06-09 |
| CA3012693C (fr) | 2022-08-23 |
| KR102487839B1 (ko) | 2023-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL287519B1 (en) | Non-human animals with a humanized programmed cell death gene 1 | |
| IL262958A (en) | Non-human animals have a human signal modulator protein gene | |
| DK3376857T3 (da) | Ikke-humane dyr, der har et humaniseret lymfocyt-aktiveringsgen 3 | |
| LT3850946T (lt) | Gyvūnai, išskyrus žmogų, turintys humanizuotą ląstelės diferenciacijos klasterio 47 geną | |
| DK3482629T3 (da) | Genmodificerede ikke-humane dyr, der eksprimerer humant epo | |
| DK3808775T3 (da) | Ikke-humaniserede dyr med en klynge af differenteringsgenet 274 | |
| MA43962A (fr) | Animaux non humains possédant un gène angptl8 modifié | |
| EP3320773A4 (fr) | Animal non-humain ayant un gène cd3 humain substitué par un gène cd3 endogène | |
| FR3021432B1 (fr) | Processeur a instructions conditionnelles | |
| IL261012A (en) | Non-human animals having a mutant kynureninase gene | |
| FR3025894B1 (fr) | Miroir a durabilite amelioree | |
| EP3725879A4 (fr) | Modèle animal non humain modifié par un gène | |
| ZA201801103B (en) | Non-human animals having a humanized signal-regulatory protein gene | |
| FI11251U1 (fi) | Linnunpönttö | |
| EP3096608C0 (fr) | Jouets pour animaux | |
| FR3031004B1 (fr) | Cage a animaux particulierement destinee aux oiseaux | |
| TH1601002070A (th) | สัตว์ที่ได้รับการฮิวมาไนซ์ด้วย il-15 |